Event
Financial Times US Pharma & Biotech Summit 2026
May 14, 2026
New York City, New York
Financial times US pharma & Biotech Summit is held in partnership with Endpoints News, focuses on the most important strategic, scientific, regulatory, and investment forces reshaping US life sciences. Expecting more than 350 attendees, 30 speakers, 200 companies, and 50 countries represented.
This summit attracts high-level stakeholders across the U.S. and global biopharmaceutical ecosystem including:
Senior Industry Leadership, Investors & Financial Stakeholders, Regulatory, Market Access & Policy Leaders, R&D, Clinical & Technology Specialists, Broader Healthcare & Patient Community. Key Themes this year include:
- AI In Life Sciences
- Dealmaking & M & A landscape
- Clinical Trial Agility & R & D Shifts
- Personalized Medicine & Advanced Therapies
- Drug Pricing, Policy & US Healthcare Dynamics
- Digital Therapeutics, & Data Innovation
- Global Supply Chain & Biosecurity
Visit us on the exhibit floor and don’t miss out on our panel participation.
Rob Goodwin
Chief Operating Officer
Thursday, May 14, 2026, 10:25 – 10:45a.m.
25 – minute keynote interview
Title – Building a patient-first culture
In today's rapidly evolving healthcare landscape, organizations that genuinely incorporate patient-focused approaches into their core operations achieve superior clinical outcomes, faster enrollment, and stronger competitive positioning. This session aims to explore how executive leadership can drive transformational change, placing patients at the heart of business decisions and clinical innovation.
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.